A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 83
◽
pp. 302-312
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7066-7066
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):